Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
Clinical trial NCT03091933 · UNKNOWN
Trial details
- NCT number
- NCT03091933
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2018-03-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.